Expression of seprase in effusions from patients with epithelial ovarian carcinoma

Chinese Medical Journal

Volumn 120, Issue 8, 2007, Pages 663-668

  Zhang, Meng Zhen ^a   Qiao, Yu Huan ^a   Nesland, Jahn M ^b   Suo, Zhen He ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Effusion; Ovarian neoplasms; Seprase

Indexed keywords

SEPRASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA CELL; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; NORWAY; OVARY CARCINOMA; PERITONEUM EXUDATE; PLEURA EFFUSION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; WESTERN BLOTTING;

EID: 34248632576     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200704020-00010     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bjorge T, Engeland A, Hansen S, Trope CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed, in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663-670.
3. Brown C, Rini B. Cancer medicine. London: BC Decker Inc; 2003: 118-130.
4. Vecchia CL. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 2001; 10: 125-129.
5. Talvensaari-Mattila A, Santala M, Soini Y, Turpeenniemi-Hujanen T. Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. Anticancer Res 2005; 25: 4101-4105.
6. Chen WT. DPPIV and seprase in cancer invasion and angiogenesis. Adv Exp Med Biol 2003; 524: 197-203.
7. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 1994; 91: 5657-5661.
8. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 1994; 54: 5702-5710.
9. Chen WT, Kelly T. Seprase complexes in cellular invasiveness. Cancer Metastasis Rev 2003; 22: 259-269.
10. Artym VV, Kindzelskii AL, Chen WT, Petty HR. Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis 2002; 23: 1593-1601.
11. Okada K, Chen WT, Iwasa S, Jin X, Yamane T, Ooi A, et al. Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology 2003; 65: 363-370.
12. Goodman JD, Rozypal TL, Kelly T. Seprase, a membrane-bound protease, alleviates the serum growth requirement of human breast cancer cells. Clin Exp Metastasis 2003; 20: 459-470.
13. Davidson B. Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, et al. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res 2003; 9: 2248-2259.
14. Suo Z, Karbovo E. Trope CG, Metodiev K, Nesland JM. Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study. Ultrastruct Pathol 2004; 28: 141-147.
15. Pineiro-Sanchez ML, Goldstein LA, Dodt J. Howard L, Yeh Y, Tran H, et al. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem 1997; 272: 7595-7601.
16. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, et al. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 2004; 23: 5435-5446.
17. Chen WT, Kelly T, Ghersi G, DPPIV, seprase, and related serine peptidases in multiple cellular functions. Curr Top Dev Biol 2003; 54: 207-232.
18. Aertgeerts K, Levin I, Shi L. Snell GP, Jennings A, Prasad GS, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem 2005; 280:19441-19444.
19. Busek P, Malik R, Sedo A. Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol 2004; 36: 408-421.
20. Mori Y, Kono K, Matsumoto Y, Fujii H, Yamane T, Mitusmata M, et al. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology 2004; 67: 411-419.
21. Iwasa S, Jin X, Okada K, Mitusmata M, Ooi A. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett 2003; 199:91-98.
22. Jin X, Iwasa S. Okada K, Mitusmata M, Ooi A. Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. Anticancer Res 2003; 23: 3195-3198.
23. Kelly T, Kechelava S, Rozypal TL, West KW, Korourian S. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol 1998; 11: 855-863.
24. Huang Y, Wang S, Kelly T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res 2004; 64: 2712-2716.
25. Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer 2001; 95: 67-72.
26. Davidson B, Reic R, Berner A, Givant-Horwitz V, Goldberg I, Risberg B, et al. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels. Eur J Cancer 2001; 37: 2040-2049.
27. Schaner ME, Davidson B, Skrede M, Reich R, Florenes VA, Risberg B, et al. Variation in gene expression patterns in effusions, and primary tumors from serous ovarian cancer patients. Mol Cancer 2005; 4: 1-14.
28. Ghersi G, Zhao Q, Salamone M, Yeh Y, Zucker S, Chen WT. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res 2006; 66: 4652-4661.